quarta-feira, 7 de outubro de 2026
PesquisarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· December 11, 2025

Costco (COST) Q1 2026 Earnings Call Transcript

View original at nasdaq.com
Costco (COST) Q1 2026 Earnings Call Transcript Image source: The Motley Fool. DATE Thursday, Dec. 11, 2025 at 5 p.m…
Opening lines of the source · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Excluding tax benefits, net income and EPS grew 13.6% year-over-year in Q1 2026

    80% confidence
  • Q1 was the first quarter where healthcare costs grew at faster pace than sales, creating SG&A headwinds

    80% confidence
  • AI pharmacy inventory system improved in-stock levels to >98% with mid-teens script fill growth

    80% confidence
  • Renewal rate may still see a slight decline over next few quarters due to digitally-signed members with lower renewal rates

    80% confidence
  • Warehouse relocations typically generate 20-60% sales uplift

    80% confidence
  • Targeted communications to expiring digitally-signed members showing early success in improving renewal rates

    80% confidence
  • Extended operating hours for executive members generated estimated ~1% sales lift

    80% confidence
  • Long-term geographic target is approximately 50% US and 50% international across Canada, Mexico, Europe, Asia, and Australia

    80% confidence
  • Kirkland Signature is growing faster than overall sales with 15-20% value proposition vs national brands

    80% confidence
  • Executive membership upgrades saw a 'nice uptick' from extended hours and Instacart benefits

    80% confidence
  • FY2025 warehouse openings are achieving $192M annualized productivity per warehouse vs $150M for FY2023 openings

    80% confidence
  • Personalization system launched in Q1 showed positive sales lift

    80% confidence
O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Autumn 2026 Biopharma Catalyst Season: Late-Breaking Data, FDA Milestones and the Rise of AI-Designed Drugs
Late-September and early-October 2026 conferences (EASD, EADV, IGCS) brought a cluster of positive late-breaking trial readouts. These covered obesity and metabolic disease (Novo Nordisk's CagriSema), immunology (Lilly's EBGLYSS, tulisokibart) and oncology (Rina-S, Agenus BOT+BAL). Ahead lie hard regulatory catalysts, led by the 14 Nov 2026 FDA PDUFA date for ivonescimab. At the same time, Insilico-style AI-designed drugs such as rentosertib are showing anti-aging signals. That points to AI-driven drug discovery moving from concept toward clinical validation. Unrelated tech and regulatory items (Tesla Cybercab probe, xAI litigation, OpenAI agent incident) and the speculative QAIAx claims are peripheral to this story.
A nossa leitura dos dados ›
Sinais que acompanhamos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Padrões que observamos ›
Onde as fontes divergem
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,986
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,986 factos verificados com a fonte5,362 documentos-fonte arquivados
Consulte estes dados → isubstrate.com
Costco (COST) Q1 2026 Earnings Call Transcript — Source | Via News | pt.VIA.NEWS